Morsch Ana Lúcia Bernardo de Carvalho, Amorim Maria Marta, Barbieri Andréa, Santoro Llka Lopes, Fernandes Ana Luisa Godoy
Universidade Regional Integrada, Erechim, RS, Brasil.
J Bras Pneumol. 2008 Dec;34(12):1026-32. doi: 10.1590/s1806-37132008001200007.
To evaluate whether respiratory therapy techniques influence the number of cells within and quantity of induced sputum in patients with asthma or chronic obstructive pulmonary disease (COPD).
Randomized clinical trial, in which patients with asthma or COPD under intervention (n = 16 and 10, respectively) were compared with control groups (n = 16 and 10). Patients in the asthma/intervention (A/I) and COPD/intervention (C/I) groups were submitted to oscillating positive expiratory pressure maneuvers for 5 min, followed by 10 forced expiratory technique sequences. These patients were also submitted to an induced sputum protocol with inhaled hypertonic saline (3%, 4% or 5%; A/I group) or inhaled isotonic saline (C/I group). The asthma/control (A/C) and COPD/control (C/C) groups were submitted only to the standard induced sputum protocol.
The final mean weight of the sputum samples was significantly greater in the A/I group than in the A/C group (2,767.25 +/- 998.08 mg vs. 1,689.17 +/- 1,189.96 mg; p = 0.03). The mean/median total cell counts (x10(6)/mL) were higher in the A/I and C/I groups than in the A/C and C/C groups (4.06/0.95 and 0.63/0.39, p = 0.05, vs. 5.08/1.77 and 0.64/0.40, p = 0.02). There were no statistically significant differences among the groups in terms of cell viability.
The use of respiratory therapy techniques can increase sputum sample weight in asthma patients, as well as increasing total cell counts in patients with asthma or COPD.
评估呼吸治疗技术是否会影响哮喘或慢性阻塞性肺疾病(COPD)患者痰液中的细胞数量和诱导痰量。
随机临床试验,将接受干预的哮喘或COPD患者(分别为n = 16和10)与对照组(n = 16和10)进行比较。哮喘/干预(A/I)组和COPD/干预(C/I)组的患者接受5分钟的振荡呼气末正压操作,随后进行10次用力呼气技术序列。这些患者还接受了吸入高渗盐水(3%、4%或5%;A/I组)或吸入等渗盐水(C/I组)的诱导痰方案。哮喘/对照组(A/C)和COPD/对照组(C/C)仅接受标准诱导痰方案。
A/I组痰液样本的最终平均重量显著高于A/C组(2,767.25 +/- 998.08毫克对1,689.17 +/- 1,189.96毫克;p = 0.03)。A/I组和C/I组的平均/中位数总细胞计数(x10(6)/毫升)高于A/C组和C/C组(4.06/0.95和0.63/0.39,p = 0.05,对5.08/1.77和0.64/0.40,p = 0.02)。各组之间在细胞活力方面无统计学显著差异。
呼吸治疗技术的使用可增加哮喘患者的痰液样本重量,以及增加哮喘或COPD患者的总细胞计数。